News & Events

Latest news & events at NeRRe Therapeutics

NeRRe Therapeutics CSO & COO, Dr Mike Trower, presents at the Endo17 satellite meeting Kisspeptin 2017, March 30th-31st, in Florida, USA on the neurokinin antagonist NT-814 and its potential utility in sex-hormone dependent diseases

Back to News & Events